Trial Profile
Effects on Exercise Hemodynamics of Vasopressin Blockade by Conivaptan Infusion in Heart Failure Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Conivaptan (Primary)
- Indications Heart failure
- Focus Biomarker; Therapeutic Use
- 16 Jun 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record..
- 18 Jan 2013 New trial record